Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does XYLOMETAZOLINE Cause Ventricular fibrillation? 139 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 139 reports of Ventricular fibrillation have been filed in association with XYLOMETAZOLINE (Metarivin Soln. 0.1%). This represents 25.8% of all adverse event reports for XYLOMETAZOLINE.

139
Reports of Ventricular fibrillation with XYLOMETAZOLINE
25.8%
of all XYLOMETAZOLINE reports
139
Deaths
107
Hospitalizations

How Dangerous Is Ventricular fibrillation From XYLOMETAZOLINE?

Of the 139 reports, 139 (100.0%) resulted in death, 107 (77.0%) required hospitalization, and 97 (69.8%) were considered life-threatening.

Is Ventricular fibrillation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for XYLOMETAZOLINE. However, 139 reports have been filed with the FAERS database.

What Other Side Effects Does XYLOMETAZOLINE Cause?

Off label use (161) Abdominal distension (155) Nausea (155) Hyponatraemia (154) Stress (152) Multiple organ dysfunction syndrome (151) Abdominal pain (149) General physical health deterioration (148) Appendicitis (147) Vomiting (147)

What Other Drugs Cause Ventricular fibrillation?

AMIODARONE (456) ONDANSETRON (436) HEPARIN (268) ACETAMINOPHEN (266) LANSOPRAZOLE (254) METRONIDAZOLE (253) ALBUTEROL (238) CEFTRIAXONE (234) SODIUM (232) ALLOPURINOL (230)

Which XYLOMETAZOLINE Alternatives Have Lower Ventricular fibrillation Risk?

XYLOMETAZOLINE vs XYREM XYLOMETAZOLINE vs XYREM , /ML XYLOMETAZOLINE vs YASMIN XYLOMETAZOLINE vs YAZ XYLOMETAZOLINE vs YTTRIUM Y-90

Related Pages

XYLOMETAZOLINE Full Profile All Ventricular fibrillation Reports All Drugs Causing Ventricular fibrillation XYLOMETAZOLINE Demographics